DR. LISA LAVANGE - Corporate Board Profile

Simulations Plus, Inc.

Filing Date	Source Excerpt
2019-12-30	DR. LISA LAVANGE was appointed as a Director of the Company as of May 1, 2019. ... Director Compensation for Fiscal Year 2019: Dr. Lisa LaVange total compensation $82,263.
2020-12-29	DR. LISA LAVANGE was appointed as a Director of the Company as of May 1, 2019. Dr. LaVange graduated from the University of North Carolina with a doctoral degree in Biostatistics. Dr. LaVange currently serves as Professor and Interim Co-Chair of the Department of Biostatistics in the Gillings School of Global Public Health at the University of North Carolina. She directs a new Master's of Public Health (MPH) in Data Science program and serves as Principal Investigator of the coordinating centers for three large and complex trial networks: the NICHD-sponsored Adolescent Medicine Trials in HIV/AIDS Interventions Network (ATN); the NHLBI-sponsored Precision Medicine in Severe and Exacerbation-Prone Asthma Network (PrecISE); and the NIAMS-sponsored Back Pain Consortium Research Program (BACPAC), which is part of the NIH HEAL Initiative to curb the opioid crisis. From 2011 to 2017, Dr. LaVange served as Director of the Office of Biostatistics in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) where she oversaw more than 200 statisticians and other staff members involved in the development and application of statistical methodology for drug regulation. She was a leader in developing and assessing the effectiveness and appropriateness of innovative statistical methods intended to accelerate the process from drug discovery to clinical trials to FDA approval and patients’ benefit. Previously, she worked for six years at one of the world’s largest pharmaceutical outsourcing services companies, Quintiles, Inc. (now IQVIA), serving as Vice President of Biostatistics for her last three years, and as Vice President, Biostatistics and Data Management, for Inspire Pharmaceuticals, Inc. Dr. LaVange is an elected fellow of the American Statistical Association (ASA) and was the 2018 ASA President. She is also former president of the Eastern North American Region of the International Biometric Society (ENAR-IBS) and former IBS Board member. Dr. LaVange’s extensive experience, knowledge, and industry expertise, makes her a qualified candidate for the Board.
2021-05-11	Dr. Lisa LaVange 2020 83,058 116,336 57,980 – 257,374 ...On July 17, 2020, the Board reviewed and approved the Nominating Committee’s recommendation to grant its non-employee directors non-qualified options to purchase common stock (“stock options”) taking into consideration market standards and the growth of the business. Options granted were; 5,000 each to Dr. Lisa LaVange...Stock options vest and become exercisable as follows: (i) no option shares will be vested prior to the grant date; and (ii) the balance of the option shares will vest annually on their anniversary date, 40% the first year, 30% the second and 30% the final year measured from the grant date, provided that there has not been a termination of service.
2021-12-17	DR. LISA LAVANGE has been a Director of the Company since May 1, 2019. ... The Board has three committees: Audit Committee, Compensation Committee, and Nominating & Corporate Governance Committee. ... Audit Committee members during fiscal year 2021: Dr. Lisa LaVange. ... Compensation Committee members during fiscal year 2021: Lisa LaVange. ... Nominating & Corporate Governance Committee members during fiscal year 2021: Dr. Lisa LaVange (Chair). ... Director Compensation for Fiscal Year 2021: Dr. Lisa LaVange total compensation $155,599.
2022-12-23	Dr. Lisa LaVange has been a director of the Company since May 1, 2019. ... Audit Committee members during fiscal year 2022: Dr. John K. Paglia (Chair), Dr. Lisa LaVange, Sharlene Evans. ... Compensation Committee members during fiscal year 2022: Dr. Daniel Weiner (Chair), Dr. Lisa LaVange, Sharlene Evans. ... Nominating & Corporate Governance Committee members during fiscal year 2022: Dr. Lisa LaVange (Chair), Dr. Daniel Weiner, Dr. John K. Paglia. ... Director Compensation Table: Dr. Lisa LaVange total compensation $134,804.
2023-12-22	Dr. Lisa LaVange has been a director of the Company since May 1, 2019. ... Dr. LaVange is currently Professor Emerita and former Chair of Biostatistics, retiring from UNC in October 2023. ... We believe that Dr. LaVange’s extensive experience, knowledge, and industry expertise make her a qualified candidate for the Board.
2024-12-23	DR. LISA LAVANGE has been a director of the Company since May 1, 2019. ... The Board has three committees: Audit Committee, Compensation Committee, and Nominating & Corporate Governance Committee. ... The table below shows all compensation awarded to, earned by or paid to our non-employee directors during the fiscal year 2024: Dr. Lisa LaVange 2024 70,000 120,071 190,071.